May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
Objective and Subjective Techniques to Clinically Assess Multi–Purpose Solutions in Symptomatic Patients
Author Affiliations & Notes
  • R.P. Stone
    Alcon Research, Ltd., Fort Worth, TX
  • L.D. Napier
    Alcon Research, Ltd., Fort Worth, TX
  • J.R. Kern
    Alcon Research, Ltd., Fort Worth, TX
  • V.A. Parkman
    Alcon Research, Ltd., Fort Worth, TX
  • J. Devenport
    Alcon Research, Ltd., Fort Worth, TX
  • C. Blalock
    Alcon Research, Ltd., Fort Worth, TX
  • D. Keith
    Alcon Research, Ltd., Fort Worth, TX
  • H. Ketelson
    Alcon Research, Ltd., Fort Worth, TX
  • Footnotes
    Commercial Relationships  R.P. Stone, Alcon Research, Ltd., E; L.D. Napier, Alcon Research, Ltd., E; J.R. Kern, Alcon Research, Ltd., E; V.A. Parkman, Alcon Research, Ltd., E; J. Devenport, Alcon Research, Ltd., E; C. Blalock, Alcon Research, Ltd., E; D. Keith, Alcon Research, Ltd., E; H. Ketelson, Alcon Research, Ltd., E.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 91. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R.P. Stone, L.D. Napier, J.R. Kern, V.A. Parkman, J. Devenport, C. Blalock, D. Keith, H. Ketelson; Objective and Subjective Techniques to Clinically Assess Multi–Purpose Solutions in Symptomatic Patients . Invest. Ophthalmol. Vis. Sci. 2006;47(13):91.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : This study was designed to evaluate the ability of both objective and subjective techniques to distinguish differences among multi–purpose solutions in patients who experience end of day discomfort.

Methods: : 367 soft contact lens wearers who reported end of day discomfort were enrolled at 22 sites in this double–masked, concurrently controlled study. Subjects were randomized to Regimen 1 (OPTI–FREE® RepleniSHTM Multi–Purpose Disinfecting Solution, Alcon Laboratories, Inc) or Regimen 2 (ReNu with MoistureLoc Multi–Purpose Solution, Bausch & Lomb). They were dispensed a new pair of their current FDA Group IV lens brand. Safety, including investigator–observed corneal staining, and efficacy were evaluated on Days 0, 14 and 28. At pre–selected sites, lenses were collected at the conclusion of the study for laboratory–measured lens lysozyme (HPLC) and ex vivo measurement of lens wettability after 14 hours of wear. Patients also rated specific product attributes using Likert style questions.

Results: : Mean corneal staining was significantly lower in subjects using Regimen 1 compared to those using Regimen 2 at Days 14 (p=0.0189) and 28 (p=0.0046). Lenses cared for with Regimen 1 had significantly less residual lysozyme than lenses cared for with Regimen 2 (p<0.0001). The mean wetting angle of lenses was significantly lower, indicating better lens wettability, for the subjects using Regimen 1 (5.3°) than for those using Regimen 2 (91.3°, p<0.0001). In addition, the mean wetting angle correlated with the subjective response regarding a feeling of moisture while wearing the lens ("When I use this solution, my lenses feel moist", r=0.426).

Conclusions: : Both objective and subjective measurements allowed for distinction among the two multi–purpose solutions. Significant differences in cleaning ability, wettability, and corneal staining were found between these two regimens. Compellingly, the wettability measurement was found to correlate with a feeling of moist lenses, thereby showing that the objective mean wetting angle measurement can be related to a subjective patient response. Doctors should consider these differences in product performance when recommending a lens care regimen.

Keywords: contact lens • cornea: clinical science 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.